Piramal Pharma Releases FY26 Sustainability Report
Piramal Pharma Limited (PPL) has released its Sustainability Report for the financial year 2025-26. The report details the company's non-financial performance across Environment, Social, and Governance (ESG) pillars. Key focus areas for FY26 included accelerating energy efficiency, increasing renewable energy use, strengthening circular economy practices, advancing water conservation, and expanding community programs in education and skill development. The report also highlights renewed attention on governance foundations, including embedding ethical practices and structured risk assessments. PPL has prepared this report in accordance with GRI Universal Standards 2021 and aligned with UN SDGs, covering its three business units: Piramal Pharma Solutions (PPS), Piramal Critical Care (PCC), and Piramal Consumer Healthcare (PCH).
Key Highlights
- Piramal Pharma released its FY26 Sustainability Report.
- Report covers ESG performance across three business units.
- Focus on energy efficiency, renewables, and circular practices.
- Strengthened governance, ethical practices, and risk assessment.
- Report aligned with GRI Standards and UN SDGs.
Price Impact
More from PPLPHARMA